|
SAV1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.52473605857995E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.11520040266566E-10 |
| Normal-vs-Stage2 |
4.03499999968027E-07 |
| Normal-vs-Stage3 |
3.39900000367876E-08 |
| Normal-vs-Stage4 |
7.93310000000158E-05 |
| Stage1-vs-Stage2 |
9.001400E-01 |
| Stage1-vs-Stage3 |
8.926400E-01 |
| Stage1-vs-Stage4 |
9.483400E-01 |
| Stage2-vs-Stage3 |
8.093000E-01 |
| Stage2-vs-Stage4 |
9.756600E-01 |
| Stage3-vs-Stage4 |
8.711400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.58140167627607E-11 |
| Normal-vs-AfricanAmerican |
6.12859996085291E-09 |
| Normal-vs-Asian |
6.992800E-04 |
| Caucasian-vs-AfricanAmerican |
6.665000E-01 |
| Caucasian-vs-Asian |
6.720800E-01 |
| AfricanAmerican-vs-Asian |
5.529200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.70092845258796E-12 |
| Normal-vs-Female |
9.07090003110511E-09 |
| Male-vs-Female |
8.594000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.39049999584529E-08 |
| Normal-vs-Extreme_Weight |
4.57329951686347E-10 |
| Normal-vs-Obese |
3.30599999598391E-08 |
| Normal-vs-Extreme_Obese |
5.94819999999441E-05 |
| Normal_Weight-vs-Extreme_Weight |
6.876800E-01 |
| Normal_Weight-vs-Obese |
2.600400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.094800E-01 |
| Extreme_Weight-vs-Obese |
3.521200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.107600E-01 |
| Obese-vs-Extreme_Obese |
5.487800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.575700E-04 |
| Normal-vs-Age(41-60Yrs) |
1.1553999978986E-09 |
| Normal-vs-Age(61-80Yrs) |
8.44757597207035E-12 |
| Normal-vs-Age(81-100Yrs) |
1.52879999992805E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.810400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.555600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.478450E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.145050E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.796400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.131400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.25359755698673E-11 |
| Normal-VS-Type2 PRCC |
1.47926115801056E-12 |
| Normal-VS-KIRP CIMP |
9.882900E-03 |
| Normal-VS-Unclassified PRCC |
1.19299999989941E-07 |
| Type1 PRCC-VS-Type2 PRCC |
2.468300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.106600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.208000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.798100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.678640E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.107400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.36002320516582E-13 |
| Normal-vs-N1 |
7.69489999999928E-05 |
| Normal-vs-N2 |
8.11660000000769E-05 |
| N0-vs-N1 |
1.477740E-02 |
| N0-vs-N2 |
1.494600E-01 |
| N1-vs-N2 |
4.755600E-02 |
|
|
